What you need to know about hepatitis C and its genotypes

Interactive

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.

From representation reflected in specialties of medical professionals, to balance within clinical trials, health equity is an ongoing evolution.

In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.

Pat, a hepatitis c survivor, shares her thoughts on disparity within the healthcare system.

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.

Learn who has higher odds of contracting this viral infection.